V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220087 | 20170063 | 1.57 | 85.6 | Palliative (P) | 2016-06-05 | 2016-06-05 | Capecitabine+Cisplatin+Streptozocin | N | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100619517 |
| 20220308 | 20170064 | 1.65 | 59.4 | Neo-adjuvant (N) | null | 2021-11-19 | CYCLOPHOSPHAMIDE + THALIDOMIDE | Y | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 100517890 |
| 20220479 | 20170065 | 1.71 | 0 | Curative (C) | 2018-09-03 | 2018-09-03 | EOF | 02 | null | GEMCITABINE + PACLITAXEL | 100467656 |
| 20224260 | 20170068 | 1.84 | 70.7 | Adjuvant (A) | 2020-06-19 | 2020-06-25 | Fluorouracil96hr infusion+RT(3g/m2) | 02 | N | CAPECITABINE + STREPTOZOCIN | 101152026 |
| 20224442 | 20170069 | 1.87 | 52.2 | Palliative (P) | 2018-09-07 | 2018-09-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | DABRAFENIB | 101312033 |
| 20224829 | 20170070 | 1.69 | 94.4 | null | 2018-10-28 | 2019-08-07 | null | 02 | null | BACILLUS CALMETTE-GUERIN | 100465200 |
| 20225073 | 20170071 | 1.47 | 84 | Palliative (P) | 2019-01-10 | 2019-01-17 | Cisplatin + Radiotherapy | 02 | null | MITOMYCIN | 100693247 |
| 20015188 | 20170074 | 1.71 | null | 03 | 2020-02-10 | 2020-02-11 | Melpahan IV Low dose | 02 | N | BENDAMUSTINE + OBINUTUZUMAB | 101757171 |
| 20018993 | 20170076 | 1.6 | null | null | 2021-08-18 | 2021-12-05 | BEAM | 02 | N | HYDROXYCARBAMIDE | 101406014 |
| 20022615 | 20170078 | 1.76 | 76.8 | Curative (C) | 2017-02-10 | 2018-09-16 | CEDAR trial | 02 | N | CAP + RT | 101570575 |
| 20033541 | 20170081 | 1.83 | 57 | Curative (C) | 2017-04-23 | 2017-04-27 | EEF or EOF | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101695090 |
| 20035688 | 20170082 | 1.86 | 0 | Neo-adjuvant (N) | 2017-07-12 | 2018-12-22 | ABVD | 02 | null | BORTEZOMIB + THALIDOMIDE | 100982369 |
| 20039364 | 20170083 | null | null | Palliative (P) | 2021-01-11 | 2021-01-25 | Azacitidine | 02 | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101090148 |
| 20039412 | 20170084 | 0.9 | 74.3 | Curative (C) | 2018-10-17 | 2018-11-07 | AFLIBERCEPT + FU + IRINOTECAN | N | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101347751 |
| 20039998 | 20170085 | 1.49 | 67.4 | Curative (C) | 2018-12-06 | 2019-04-22 | Liposomal Doxorubicin (Caelyx) | 02 | null | AXITINIB | 101839329 |
| 20040304 | 20170086 | 1.55 | 58.9 | null | 2020-10-22 | 2020-10-29 | Docetaxel+Gemcitabine (no prior RT) | 02 | null | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 100597632 |
| 20040612 | 20170087 | null | null | Palliative (P) | 2018-02-25 | 2018-02-25 | ESHAP | 02 | N | RITUXIMAB | 101227502 |
| 20044417 | 20170088 | 1.51 | 68.3 | 03 | 2021-04-05 | 2021-04-12 | ECarboX | 02 | N | MPV | 101641616 |
| 20046134 | 20170089 | 1.65 | 63.7 | null | 2018-05-25 | 2018-06-20 | Cape+Cetuximab+Oxalip (2 wk) Load | 02 | N | CYCLOPHOSPHAMIDE | 100443890 |
| 20049933 | 20170091 | 1.75 | 108.3 | Palliative (P) | null | 2018-07-19 | Pemigatinib | N | N | TRABECTEDIN | 100460285 |
| 20051858 | 20170092 | 1.52 | 0 | Palliative (P) | 2017-08-21 | 2017-09-25 | GO2 TRIAL | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 101811196 |
| 20051949 | 20170093 | 1.65 | 68.6 | Palliative (P) | 2021-07-11 | 2021-08-28 | Topotecan (oral) | 2 | Y | DOCETAXEL + GEMCITABINE | 100930921 |
| 20054283 | 20170094 | 1.71 | 83.8 | Curative (C) | 2017-02-05 | 2017-03-05 | CAV | 02 | Y | IDELALISIB | 100040411 |
| 20058058 | 20170095 | 1.48 | null | null | 2019-09-29 | 2019-10-06 | BEAM | 01 | null | BUSULPHAN | 100370115 |
| 20062437 | 20170097 | 1.69 | 107 | Palliative (P) | 2017-11-23 | 2017-11-28 | CISPLATIN + FLUOROURACIL + RT | 02 | N | GEMCITABINE + PACLITAXEL | 101004426 |
| 20065210 | 20170098 | 1.71 | 79.7 | null | 2022-02-25 | 2022-04-24 | CHLORAMBUCIL + OBINUTUZUMAB | 01 | null | RITUXIMAB | 100023013 |
| 20065293 | 20170099 | 1.55 | 65 | Palliative (P) | 2020-01-05 | 2020-02-05 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | Y | CETUXIMAB + IRINOTECAN | 100738854 |
| 20065775 | 20170100 | 1.52 | 65 | Curative (C) | null | 2019-02-02 | Rituximab | N | null | GEMCARBO | 101764724 |
| 20073243 | 20170102 | 1.61 | 54 | Palliative (P) | 2021-05-12 | 2021-06-04 | CEMIPLIMAB | 02 | Y | VINORELBINE | 100198859 |
| 20084150 | 20170103 | 1.51 | 69.7 | Palliative (P) | 2018-07-26 | 2018-07-28 | DABRAFENIB + TRAMETINIB | 02 | null | EOF | 100861511 |
| 20092444 | 20170104 | 1.55 | 88.46 | null | 2017-09-23 | 2017-10-10 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | null | DARATUMUMAB | 100058981 |
| 20104742 | 20170105 | 1.75 | 69.3 | Palliative (P) | null | 2021-12-18 | IPILIMUMAB + NIVOLUMAB | 02 | N | FULVESTRANT + RIBOCICLIB | 101354924 |
| 20112612 | 20170106 | 1 | 67.9 | Palliative (P) | 2018-07-10 | 2018-08-07 | AFATINIB | N | null | CAPECITABINE + STREPTOZOCIN | 101479073 |
| 20112952 | 20170107 | 1.65 | 63.4 | Palliative (P) | 2018-07-24 | 2018-07-24 | CETUXIMAB + MDG | N | null | FLUOROURACIL + RT | 101726390 |
| 20148062 | 20170109 | 1.64 | 71.2 | Palliative (P) | 2020-10-10 | 2021-02-10 | Cisplatin + Fluorouracil + RT 5day | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100374110 |
| 20152132 | 20170110 | 1.56 | 60.2 | null | null | 2021-09-17 | Capecitabine + Streptozocin | Y | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100979015 |
| 20175995 | 20170113 | 1.54 | 73.85 | 03 | 2021-06-23 | 2021-06-23 | Carboplatin + Vinorelbine Oral | 01 | N | BACILLUS CALMETTE-GUERIN | 100735644 |
| 20199357 | 20170114 | 0 | 61.5 | 03 | 2019-10-09 | 2019-10-11 | Topotecan (oral) | 02 | N | SCOPE2 TRIAL | 100441603 |
| 20200913 | 20170115 | null | 59.8 | Curative (C) | 2021-07-08 | 2021-08-12 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 02 | N | CHOP R | 100060037 |
| 20205619 | 20170117 | 1.85 | 21.2 | Neo-adjuvant (N) | 2019-05-29 | 2019-07-31 | Atezolizumab | 02 | N | TOPOTECAN | 101747743 |
| 20211066 | 20170118 | 1.85 | 70 | Palliative (P) | 2022-05-12 | 2022-05-23 | Alectinib | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 100559799 |
| 20219760 | 20170119 | 1.69 | null | null | 2018-06-22 | 2018-06-26 | null | 02 | null | BORTEZOMIB + THALIDOMIDE | 100369989 |
| 20220027 | 20170120 | 1.75 | 63 | null | 2021-07-16 | 2021-07-30 | STAMPEDE TRIAL | 02 | N | GEMCITABINE + OXALIPLATIN | 101100293 |
| 20225316 | 20170121 | 1.77 | 95 | null | 2018-06-24 | 2018-07-20 | Cetuximab + Irinotecan (Cycle 1) | 01 | null | CYTARABINE + DAUNORUBICIN | 101453265 |
| 20024555 | 20170122 | 1.79 | 47.2 | null | 2016-11-13 | 2016-11-19 | PCV | 02 | N | INTERAACT TRIAL | 101122635 |
| 20046077 | 20170123 | 1.58 | 57 | null | 2019-05-26 | 2020-01-11 | Capecitabine + Docetaxel | 02 | null | FOXFIRE TRIAL | 100829353 |
| 20046135 | 20170124 | 1.73 | 87.1 | Palliative (P) | 2020-07-21 | 2020-07-21 | MITOMYCIN | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100166988 |
| 20048490 | 20170125 | 1.57 | 40 | Palliative (P) | 2017-09-02 | 2017-09-16 | Fluorouracil + Folinic + RT Bossett | N | N | PHITT D CARBOPLATIN/DOXORUBICIN | 100913682 |
| 20070602 | 20170127 | 1.82 | 47 | Palliative (P) | 2021-02-19 | 2021-02-25 | Doxorubicin 20mg/m2 7 day | 02 | null | GEMCITABINE + RT | 101417571 |
| 20205657 | 20170128 | 1.86 | 13 | Curative (C) | 2020-07-04 | 2020-08-05 | BEAM | N | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101761467 |